Consensus statements	Level	Grade
•There is good data to suggest that adjuvant adoptive immunotherapy with cytokine-induced killer cells improves survival in patients undergoing resection or loco-regional therapy; however, studies from India are lacking. Hence, it cannot be recommended for clinical use outside of clinical trials, till more data emerge from India.	I	Weak